Bliss GVS Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 31, 2025
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has notified the stock exchanges about its 40th Annual General Meeting (AGM) scheduled for Thursday, July 31, 2025, at 11:30 a.m., to be held via video conference. Key items on the agenda include adoption of audited financial statements for FY25, declaration of a final dividend of ₹0.50 per equity share (50% on face value of ₹1), and re-appointment of Dr. Vibha Gagan Sharma as director, who retires by rotation. Shareholders will also consider appointing M/s. AVS & Associates as Secretarial Auditors for a 5-year term covering FY26 to FY30. The record date for dividend eligibility is July 24, 2025, and the final dividend, if approved, will be paid on or before August 30, 2025. Remote e-voting facility will be open from July 28 to July 30, 2025, via CDSL.
Routine AGM notice; the ₹0.50 per share final dividend is subject to shareholder approval at the meeting. Investors holding shares as of July 24, 2025 will be eligible for the dividend, with payment expected by August 30, 2025. No material surprise for shareholders.